| Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uric acid measurement (procedure)
|
1463 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 3 | 2018 | 2019 | ||||||||
Diastolic blood pressure
|
1037 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||||||
Glomerular Filtration Rate
|
1033 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
Mean blood pressure
|
344 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||||||
Systolic Pressure
|
1931 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 2 | 2018 | 2018 | ||||||||
Activated Partial Thromboplastin Time measurement
|
44 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Alanine aminotransferase measurement
|
77 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Aspartate aminotransferase measurement
|
76 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Blood urea nitrogen measurement
|
174 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Chloride measurement
|
19 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Corpuscular Hemoglobin Concentration Mean
|
4389 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Creatinine measurement, serum (procedure)
|
243 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
elevated blood glucose level
|
111 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Finding of Mean Corpuscular Hemoglobin
|
1206 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Glucose measurement
|
111 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
High density lipoprotein measurement
|
1440 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Hypertensive disease
|
1085 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Low density lipoprotein cholesterol measurement
|
1142 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Mean Corpuscular Volume (result)
|
549 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Red Blood Cell Count measurement
|
1599 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Serum Alanine Aminotransferase Measurement
|
77 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Serum gamma-glutamyl transferase measurement
|
108 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Sodium measurement
|
69 | 12 | 111280427 | intron variant | C/A;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
Caffeine related disorders
|
56 | 12 | 111280427 | intron variant | C/A;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 |